Strengthening Regulatory Systems to Improve Global Food and Medical Product Quality and Safety (U01) Clinical Trials Not Allowed

This Cooperative Agreement represents the continuation and further expansion of well-established collaborations between the World Health Organization (WHO) and the Food and Drug Administration (FDA), in support of data-driven and science-based public health strategies and approaches that align well with FDA domestic and global goals. This cooperative agreement is expected to contribute to the knowledge base of the current food and medical products safety globally and address specific challenges in the global efforts to ensure safety of such products. Relevant strategies include: 1) developing global norms and standards; 2) articulating evidence-based policy options, including those relating to regulatory systems performance; and 3) providing technical support to national regulatory authorities and governments through systems strengthening efforts.